Ingrid Libman is an associate professor in the Division of Endocrinology and director of the Diabetes Program at UPMC Children’s Hospital of Pittsburgh. She also holds a secondary appointment in the Pitt Graduate School of Public Health, Department of Epidemiology. Her scientific interests focus on the etiology, prediction, prevention and management of diabetes in childhood.

Libman has extensive experience in the area of population-based epidemiology and clinical research, more recently evaluating the impact of obesity and insulin resistance in youth with type 1 diabetes and novel therapies for prevention and treatment of type 1 and type 2 diabetes in the pediatric population. Libman has been involved in numerous national and international multi-center studies over the years, having been co-chair of a multicenter clinical trial in the US to evalute the use of metformin in overweight adolescents with type 1 diabetes funded by JDRF, principal investigator for the Pittsburgh Center in the T1D Exchange funded by the Helmsley Foundation and currently principal investigator of the University of Pittsburgh center for the NIH funded TrialNet study. 

Libman has been very committed to service at the national and international level. She has served as consultant for the Pan American Health Organization, as well as Chair of the Diabetes in Youth Interest Group of the American Diabetes Association and member of the Advisory Council of the International Society for Pediatric and Adolescent Diabetes.